Brief: Diasorin Q1 Adj. EBITDA EUR 313 Mln
06/05/2025 16:44
May 6 (Reuters) - DiaSorin SpA DIAS.MI: Q1 REVENUE EUR 313 MILLION Q1 NET PROFIT EUR 52 MILLION Q1 ADJUSTED EBITDA EUR 107 MILLION CONFIRMS 2025 GUIDANCE Further company coverage: DIAS.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on DiaSorin SpA
See all newsKepler sees European Medtech recovery, starts BioMerieux at 'Buy' as top pick
Brief: Diasorin Receives Us' FDA 510(K) Clearance And Clia Waiver For Liaison Nes Group A Streptococcus (Gas) Assay
Deutsche Bank cuts Diasorin to 'sell', sees company targets as stretched
Italy - Factors to watch on June 5
Italy's DiaSorin jumps after Betaville reports possible takeover interest